Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Rheumatology Rheumatology for March/April 2020 Price increases for RA biologics keep out-of-pocket costs high for Medicare patients, Sacroiliac bone marrow edema on MRI may be common postpartum, Proximal fractures linked to higher mortality, Financial incentives affect the adoption of biosimilars, Most e-consults not followed by specialist visit, More must reads Rheumatology for January/February 2020 Comparison shows tighter treat-to-target approach provides better outcomes in RA, Tramadol Use for Noncancer Pain Linked With Increased Hip Fracture Risk, Fast-Tracked Surgery for Hip Fracture Does Not Reduce Mortality, Zoledronate Promotes Postdenosumab Bone Retention, Prednisolone scores for hand OA, More must readsRheumatology for November/December 2019 Vitamin D Alone Does Not Reduce Fracture Risk, Osteoporotic Fracture Risk is Undermanaged in Older Adults, Well-Tolerated Topical Capsaicin Formulation Reduces Knee OA Pain, Hydroxychloroquine Prevents Congenital Heart Block Recurrence in Anti-Ro Pregnancies, Repeat LTBI Testing Best in Patients Taking Biologics With New Risk Factors, More must readsRheumatology for September/October 2019 Ankylosing Spondylitis, Axial PsA May Be Two Different Diseases, Corticosteroid Use in Pregnancy Linked to Preterm Birth, Multiple Zoledronic Acid Doses May Be Needed After Stopping Denosumab, Romosozumab Benefits Osteoporosis Patients Regardless of Renal Insufficiency, Osteoporosis Remains a Costly Burden to Older US Adults, More must readsRheumatology for July/August 2019 How Common is Accelerated Knee OA in Women?, Bisphosphonates Before Denosumab May Prevent Postdenosumab BMD Rebound Effect, Occupational Therapy Program Helps Thumb OA, Weight Loss in Knee OA Patients Sustained With Liraglutide, Flu Vaccine Succeeds in TNF Inhibitor Users, More must readsPages« first 1 2 3 4 5 last »
